Jean‐Claude Tardif

61.5k total citations · 18 hit papers
536 papers, 29.6k citations indexed

About

Jean‐Claude Tardif is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Jean‐Claude Tardif has authored 536 papers receiving a total of 29.6k indexed citations (citations by other indexed papers that have themselves been cited), including 301 papers in Cardiology and Cardiovascular Medicine, 183 papers in Surgery and 107 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Jean‐Claude Tardif's work include Cardiac Imaging and Diagnostics (95 papers), Lipoproteins and Cardiovascular Health (90 papers) and Coronary Interventions and Diagnostics (75 papers). Jean‐Claude Tardif is often cited by papers focused on Cardiac Imaging and Diagnostics (95 papers), Lipoproteins and Cardiovascular Health (90 papers) and Coronary Interventions and Diagnostics (75 papers). Jean‐Claude Tardif collaborates with scholars based in Canada, United States and France. Jean‐Claude Tardif's co-authors include Philippe Gabríel Steg, Christie M. Ballantyne, Martial G. Bourassa, Michał Tendera, Stephen J. Nicholls, Kim Fox, Roberto Ferrari, Deepak L. Bhatt, Philip J. Barter and James H. Revkin and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and The Lancet.

In The Last Decade

Jean‐Claude Tardif

520 papers receiving 28.8k citations

Hit Papers

Effects of Torcetrapib in Patients at High Risk for Coron... 2005 2026 2012 2019 2007 2018 2015 2006 2012 500 1000 1.5k 2.0k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Effects of Torcetrapib in Patients at High Risk for Coronary Events
    2007 2.2k citations Jean‐Claude Tardif et al. New England Journal of Medicine profile →
  2. Cardiovascular Risk Reduction with Icosapent Ethyl for Hypertriglyceridemia
    2018 2.0k citations Deepak L. Bhatt, Philippe Gabríel Steg et al. New England Journal of Medicine profile →
  3. Lixisenatide in Patients with Type 2 Diabetes and Acute Coronary Syndrome
    2015 1.7k citations Jean‐Claude Tardif et al. New England Journal of Medicine profile →
  4. Effect of Very High-Intensity Statin Therapy on Regression of Coronary Atherosclerosis
    2006 1.5k citations Steven E. Nissen, Stephen J. Nicholls et al. profile →
  5. Effects of Dalcetrapib in Patients with a Recent Acute Coronary Syndrome
    2012 1.5k citations Christie M. Ballantyne, Stephen J. Nicholls et al. New England Journal of Medicine profile →
  6. Resting Heart Rate in Cardiovascular Disease
    2007 805 citations Philippe Gabríel Steg, Jean‐Claude Tardif et al. profile →
  7. Effect of Torcetrapib on the Progression of Coronary Atherosclerosis
    2007 713 citations Steven E. Nissen, Jean‐Claude Tardif et al. New England Journal of Medicine profile →
  8. Lipoprotein(a) Reduction in Persons with Cardiovascular Disease
    2020 641 citations Jean‐Claude Tardif et al. New England Journal of Medicine profile →
  9. Long-term prognostic value of resting heart rate in patients with suspected or proven coronary artery disease
    2005 605 citations Jean‐Claude Tardif et al. European Heart Journal profile →
  10. Effects of Reconstituted High-Density Lipoprotein Infusions on Coronary Atherosclerosis<SUBTITLE>A Randomized Controlled Trial</SUBTITLE>
    2007 576 citations Jean‐Claude Tardif profile →
  11. Women and men with stable coronary artery disease have similar clinical outcomes: insights from the international prospective CLARIFY registry
    2012 505 citations Philippe Gabríel Steg, Jean‐Claude Tardif et al. European Heart Journal profile →
  12. Safety and efficacy of dalcetrapib on atherosclerotic disease using novel non-invasive multimodality imaging (dal-PLAQUE): a randomised clinical trial
    2011 377 citations Christie M. Ballantyne, Jean‐Claude Tardif et al. profile →
  13. Ivabradine in Stable Coronary Artery Disease without Clinical Heart Failure
    2014 320 citations Philippe Gabríel Steg, Jean‐Claude Tardif et al. New England Journal of Medicine profile →
  14. Cardiovascular event rates and mortality according to achieved systolic and diastolic blood pressure in patients with stable coronary artery disease: an international cohort study
    2016 298 citations Jean‐Claude Tardif, Deepak L. Bhatt et al. profile →
  15. Colchicine in Cardiovascular Disease: In-Depth Review
    2022 171 citations Jean‐Claude Tardif et al. Circulation profile →
  16. Apolipoprotein C-III reduction in subjects with moderate hypertriglyceridaemia and at high cardiovascular risk
    2021 146 citations Jean‐Claude Tardif, Christie M. Ballantyne et al. European Heart Journal profile →
  17. Inflammation in heart failure: pathophysiology and therapeutic strategies
    2024 47 citations Jean‐Claude Tardif et al. profile →
  18. Long-term trials of colchicine for secondary prevention of vascular events: a meta-analysis
    2025 18 citations Marie‐Pierre Dubé, Jean‐Claude Tardif et al. European Heart Journal profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jean‐Claude Tardif Canada 71 12.9k 12.3k 8.0k 4.8k 3.2k 536 29.6k
Ulf Landmesser Germany 86 15.2k 1.2× 10.8k 0.9× 4.4k 0.6× 7.0k 1.5× 3.9k 1.2× 574 34.0k
Stephen J. Nicholls Australia 83 8.8k 0.7× 17.1k 1.4× 9.0k 1.1× 4.7k 1.0× 4.9k 1.5× 684 30.6k
Erik S.G. Stroes Netherlands 93 8.2k 0.6× 13.9k 1.1× 6.8k 0.8× 5.1k 1.1× 1.2k 0.4× 496 29.5k
Christopher J. O’Donnell United States 94 16.7k 1.3× 6.9k 0.6× 5.4k 0.7× 6.3k 1.3× 4.0k 1.3× 332 37.7k
Ulrich Laufs Germany 82 9.6k 0.7× 10.6k 0.9× 3.7k 0.5× 7.3k 1.5× 1.3k 0.4× 507 28.3k
J. Wouter Jukema Netherlands 97 14.3k 1.1× 19.8k 1.6× 7.5k 0.9× 5.1k 1.1× 8.2k 2.6× 895 41.5k
John Kjekshus Norway 68 15.7k 1.2× 11.0k 0.9× 6.1k 0.8× 2.6k 0.5× 2.6k 0.8× 238 28.2k
Arshed A. Quyyumi United States 86 14.8k 1.1× 5.5k 0.4× 3.5k 0.4× 5.0k 1.1× 4.1k 1.3× 484 29.7k
Kausik K. Ray United Kingdom 78 6.7k 0.5× 14.7k 1.2× 10.2k 1.3× 5.0k 1.1× 1.1k 0.4× 466 26.5k
Lina Badimón Spain 86 13.8k 1.1× 11.7k 1.0× 3.0k 0.4× 7.8k 1.6× 3.5k 1.1× 700 35.1k

Countries citing papers authored by Jean‐Claude Tardif

Since Specialization
Citations

This map shows the geographic impact of Jean‐Claude Tardif's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jean‐Claude Tardif with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jean‐Claude Tardif more than expected).

Fields of papers citing papers by Jean‐Claude Tardif

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jean‐Claude Tardif. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jean‐Claude Tardif. The network helps show where Jean‐Claude Tardif may publish in the future.

Co-authorship network of co-authors of Jean‐Claude Tardif

This figure shows the co-authorship network connecting the top 25 collaborators of Jean‐Claude Tardif. A scholar is included among the top collaborators of Jean‐Claude Tardif based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jean‐Claude Tardif. Jean‐Claude Tardif is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tastet, Olivier, Ahmad Hayek, Jean‐Claude Tardif, et al.. (2024). Evaluation of stenoses using AI video models applied to coronary angiography. npj Digital Medicine. 7(1). 138–138. 10 indexed citations
2.
Bhatt, Deepak L., Michael Miller, Eliot A. Brinton, et al.. (2024). Icosapent ethyl following acute coronary syndrome: the REDUCE-IT trial. European Heart Journal. 45(13). 1173–1176. 13 indexed citations
3.
Azab, Sandi M., Dany Doiron, Karleen Schulze, et al.. (2024). Exposure to air pollutants and subclinical carotid atherosclerosis measured by magnetic resonance imaging: A cross-sectional analysis. PLoS ONE. 19(10). e0309912–e0309912. 1 indexed citations
4.
Sun, Maxine, et al.. (2023). Somatic Mosaic Chromosomal Alterations and Death of Cardiovascular Disease Causes among Cancer Survivors. Cancer Epidemiology Biomarkers & Prevention. 32(6). 776–783. 3 indexed citations
5.
Hiram, Roddy, Feng Xiong, Patrice Naud, et al.. (2023). An inflammation resolution–promoting intervention prevents atrial fibrillation caused by left ventricular dysfunction. Cardiovascular Research. 120(4). 345–359. 14 indexed citations
6.
Perreault, Louis‐Philippe Lemieux, et al.. (2022). ExPheWas: a platform for cis -Mendelian randomization and gene-based association scans. Nucleic Acids Research. 50(W1). W305–W311. 8 indexed citations
7.
8.
Labbé, Pauline, Nathalie Thorin‐Trescases, Louis Villeneuve, et al.. (2022). Angiopoietin-like 2 is essential to aortic valve development in mice. Communications Biology. 5(1). 1277–1277. 7 indexed citations
9.
Luu, Judy, Cathérine Gebhard, Chinthanie Ramasundarahettige, et al.. (2022). Normal sex and age-specific parameters in a multi-ethnic population: a cardiovascular magnetic resonance study of the Canadian Alliance for Healthy Hearts and Minds cohort. Journal of Cardiovascular Magnetic Resonance. 24(1). 2–2. 23 indexed citations
10.
Stienen, Susan, Ankeet S. Bhatt, João Pedro Ferreira, et al.. (2020). Bias in natriuretic peptide-guided heart failure trials: time to improve guideline adherence using alternative approaches. Heart Failure Reviews. 26(1). 11–21. 1 indexed citations
11.
Peddu, Vikas, Isabelle Dubuc, Annie Gravel, et al.. (2019). Inherited Chromosomally Integrated Human Herpesvirus 6 Demonstrates Tissue-Specific RNA Expression In Vivo That Correlates with an Increased Antibody Immune Response. Journal of Virology. 94(1). 20 indexed citations
12.
Wünnemann, Florian, et al.. (2019). Validation of Genome-Wide Polygenic Risk Scores for Coronary Artery Disease in French Canadians. Circulation Genomic and Precision Medicine. 12(6). e002481–e002481. 46 indexed citations
13.
Bhatt, Deepak L., Philippe Gabríel Steg, Michael Miller, et al.. (2018). Cardiovascular Risk Reduction with Icosapent Ethyl for Hypertriglyceridemia. New England Journal of Medicine. 380(1). 11–22. 2003 indexed citations breakdown →
14.
Aflaki, Mona, Xiaoyan Qi, Ling Xiao, et al.. (2014). Exchange Protein Directly Activated by cAMP Mediates Slow Delayed-Rectifier Current Remodeling by Sustained β-Adrenergic Activation in Guinea Pig Hearts. Circulation Research. 114(6). 993–1003. 45 indexed citations
15.
Harada, Masafumi, Xiaobin Luo, Xiao Yan Qi, et al.. (2012). Transient Receptor Potential Canonical-3 Channel–Dependent Fibroblast Regulation in Atrial Fibrillation. Circulation. 126(17). 2051–2064. 210 indexed citations
16.
Mintz, Gary S., Hector Garcia-Garcia, Stephen J. Nicholls, et al.. (2011). Clinical expert consensus document on standards for acquisition, measurement and reporting of intravascular ultrasound regression/progression studies. EuroIntervention. 6(9). 1123–1130. 110 indexed citations
17.
Li, Baoqiang, Léonie Rouleau, Tina Lam, et al.. (2011). Low-cost three-dimensional imaging system combining fluorescence and ultrasound. Journal of Biomedical Optics. 16(12). 126010–126010. 14 indexed citations
18.
Beaulieu, Yanick, André Denault, Pierre Couture, et al.. (2009). Perioperative Intravenous Amiodarone Does Not Reduce the Burden of Atrial Fibrillation in Patients Undergoing Cardiac Valvular Surgery. Anesthesiology. 112(1). 128–137. 27 indexed citations
19.
Nicholls, Stephen J., E. Murat Tuzcu, Danielle M. Brennan, Jean‐Claude Tardif, & Steven E. Nissen. (2008). Cholesteryl Ester Transfer Protein Inhibition, High-Density Lipoprotein Raising, and Progression of Coronary Atherosclerosis. Circulation. 118(24). 2506–2514. 157 indexed citations
20.
Guerra, Peter G., Bernard Thibault, Marc Dubuc, et al.. (2003). Identification of atrial tissue in pulmonary veins using intravascular ultrasound. Journal of the American Society of Echocardiography. 16(9). 982–987. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ulf Landmesser Breakdown of academic impact, for papers by Stephen J. Nicholls Breakdown of academic impact, for papers by Erik S.G. Stroes Breakdown of academic impact, for papers by Christopher J. O’Donnell Breakdown of academic impact, for papers by Ulrich Laufs Breakdown of academic impact, for papers by J. Wouter Jukema Breakdown of academic impact, for papers by John Kjekshus Breakdown of academic impact, for papers by Arshed A. Quyyumi Breakdown of academic impact, for papers by Kausik K. Ray Breakdown of academic impact, for papers by Lina Badimón
Rankless by CCL
2026